Showing results 1 to 2 of 2
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma Yoon, Dok Hyun; Koh, Youngil; Jung, Miyoung; Kwak, Jeong-Eun; Shin, Eui-Cheol; Hwang, Yu Kyeong; Kim, Won Seog, TRANSPLANTATION AND CELLULAR THERAPY, v.29, no.4, pp.253e1 - 253e9, 2023-04 |
Soluble c receptor attenuates anti-tumor responses of CD8(+) T cells in T cell immunotherapy Kim, Geona; Hwang, Hyunju; Jo, Yuna; Lee, Byunghyuk; Lee, Young-Ho; Kim, Chan Hyuk; Hong, Changwan, INTERNATIONAL JOURNAL OF CANCER, v.143, no.5, pp.1212 - 1223, 2018-09 |
Discover